Seroconversion of hepatitis B surface antigen among those with previously successful immune response in Southern China

References

• Gong J, Li RC, Yang JY, Li YP, Chen XR, Xu ZY, Liu CB, Cao HL, Zhao K, Ni DM. Long-term efficacy of infant hepatitis B immunization program. Chin J Hepatol. 2003;11(4):203–05.
   PubMedGoogle Scholar
• Wang SS, Xu ZY, Maynard JE, Prince AM, Beasley RP, Yang JY, Li YC, Nong YZ. Evaluation of the hepatitis B model immunization program in Long-An County, China. Guangxi Prev Med. 1995;1(1):1–4.
   Google Scholar
• Ogholikhan S, Schwarz KB. Hepatitis Vaccines. Vaccines. 2016;4:6. doi:10.3390/vaccines4010006.
   Web of Science ®Google Scholar
• Li RC, Yang JY, Wang SS. The effect of hepatitis B vaccination on epidemiology of hepatitis virus. Chin J Vaccines and Immunization. 1996;2(2):56–60.
   Google Scholar
• Ministry of Health. Protocol of viral hepatitis prevention and treatment. Beijing, China: The Ministry of Health of PRC; 1984.
   Google Scholar
• Wang F, Shen L, Cui F, Zhang S, Zheng H, Zhang Y, Liang X, Wang F, Bi S. The long-term efficacy, 13–23 years, of a plasma-derived hepatitis B vaccine in highly endemic areas in China. Vaccine. 2015;33:2704–09. doi:10.1016/j.vaccine.2015.03.064.
   PubMed Web of Science ®Google Scholar
• Shen LP, Yang JY, Mo ZJ, Li RC, Li YP, Wei ZL, Dong YH, Zhou KJ, Wei SC, Fang KX, Yu T. Variation of hepatitis B virus infection epidemic pattern after long term HBV vaccine immunization. Chin J of Exp Clin Virol. 2007 Sep;21(3):253–55.
   PubMedGoogle Scholar
• Li H, Li GJ, Chen QY, Fang ZL, Wang XY, Tan C, Yang QL, Wang FZ, Wang F, Zhang S, Bi SL. Long-term effectiveness of plasma-derived hepatitis B vaccine 22–28 years after immunization in a hepatitis B virus endemic rural area: is an adult booster dose needed? life history traits of the higher trophic level parasitoid Meteorus pulchricornis (Hymenoptera: braconidae). Epidemiol Infect. 2017:1–8. © Cambridge University Press. doi:10.1017/S0950268816003046.
   Google Scholar
• Lin YC, Chang MH, Ni YH, Hsu HY, Chen DS. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis. 2003;187:134–38. PMID:12508157. doi:10.1086/345871.
   PubMed Web of Science ®Google Scholar
• Lee PI, Lee CY, Huang LM, Chang MH. Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen. J Pediatr. 1995;126:716–21. PMID:7751994. doi:10.1016/S0022-3476(95)70398-5.
   PubMed Web of Science ®Google Scholar
• Tilzey AJ. Hepatitis B vaccine boosting: the debate continues. Lancet. 1995;345:1000–01. doi:10.1016/S0140-6736(95)90751-3.
   PubMed Web of Science ®Google Scholar
• Wainwright RB, McMahon BJ, Bulkow LR, Parkinson AJ, Harpster AP. Protection provided by hepatitis B vaccine in a Yupik Eskimo population. Seven-year results. Arch Intern Med. 1991;151:1634–36. doi:10.1001/archinte.1991.00400080118023.
   PubMedGoogle Scholar
• Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011;53:68–75. PMID:21653306. doi:10.1093/cid/cir270.
   PubMed Web of Science ®Google Scholar
• Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, Su IJ, Kuo HS, Huang LM, Chen DS, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15–18 years after neonatal immunization. J Infect Dis. 2008;197:1419–26. PMID:18444799. doi:10.1086/587695.
   PubMed Web of Science ®Google Scholar
• Poovorawan Y, Chongsrisawat V, Theamboonlers A, Bock HL, Leyssen M, Jacquet JM. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. Vaccine. 2010;28:730–36. PMID:19892043. doi:10.1016/j.vaccine.2009.10.074.
   PubMed Web of Science ®Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Epidemiological serosurvey of hepatitis B in China – declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009 Nov 5;27(47):6550–57. PMID: 19729084. doi:10.1016/j.vaccine.2009.08.048.
   PubMed Web of Science ®Google Scholar
• Cui F, Shen L, Li L, Wang H, Wang F, Bi S, Liu J, Zhang G, Wang F, Zheng H, et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis. 2017 May;23(5):765–72. PMID: 28418296. doi:10.3201/eid2305.161477.
   PubMed Web of Science ®Google Scholar
• Qiuyun D, Ge Z, Wei L, Jinghang W, Rencong Y, Jinfa D, Aihu D, Ying H. Sero-prevalence of hepatitis B among people aged 1-59 years in Guangxi Zhuang Autonomous Region. Chin J Vaccines and Immunization. 2018 Feb;26(1):25–29.
   Google Scholar
• Hai L, Guo-jian L, Kong-xiong F, Qiu-feng N, Qin-yan C, Xue-yan W, Chao Q, Qing-li Y, Fu-zhen W. Study on long-term efficacy of plasma-derived hepatitis B vaccine in Long an County, Guangxi [in Chinese]. China Trop Med. 2016 Jul;16(7):645–48. PMID:23249904. doi: 10.1097/INF.0b013e31827bd1b0.
   Google Scholar
• Poovorawan Y, Chongsrisawat V, Theamboonlers A, Crasta PD, Messier M, Hardt K. Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand. Hum Vaccin Immunother. 2013;9:1679–84. PMID:23732904. doi:10.4161/hv.24844.
   PubMedGoogle Scholar
• Jan CF, Huang KC, Chien YC, Greydanus DE, Davies HD, Chiu TY, Huang LM, Chen CJ, Chen DS. Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology. 2010;51:1547–54. PMID:20209603. doi:org/10.1002/hep.23543.
   PubMed Web of Science ®Google Scholar
• Bruce MG, Bruden D, Hurlburt D, Zanis C, Thompson G, Rea L, Toomey M, Townshend-Bulson L, Rudolph K, Bulkow L, et al. Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose. J Infect Dis. 2016;214:16–22. PMID:26802139. doi:10.1093/infdis/jiv748.
   PubMed Web of Science ®Google Scholar
• Coppola N, Loquercio G, Tonziello G, Azzaro R, Pisaturo M, Di Costanzo G, Starace M, Pasquale G, Cacciapuoti C, Petruzziello A. HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient. J Clin Virol. 2013;58:315–17. PMID: 23856167. doi:10.1016/j.jcv.2013.06.020.
   PubMed Web of Science ®Google Scholar
• Zanetti AR, Tanzi E, Manzillo G, Maio G, Sbreglia C, Caporaso N, Thomas H, Zuckerman AJ. Hepatitis B variant in Europe. Lancet. 1988;2:1132–33. PMID: 2460710. doi:10.1016/S0140-6736(88)90541-7.
   PubMed Web of Science ®Google Scholar
• Chaves SS, Fischer G, Groeger J, Patel PR, Thompson ND, Teshale EH, Stevenson K, Yano VM, Armstrong GL, Samandari T, et al. Persistence of long-term immunity to hepatitis B among adolescents immunized at birth. Vaccine. 2012;30:1644–49. PMID:22245310. doi:10.1016/j.vaccine.2011.12.106.
   PubMed Web of Science ®Google Scholar
• Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990;336:325–29. PMID: 1697396. doi:10.1016/0140-6736(90)91874-A.
   PubMed Web of Science ®Google Scholar
• François G, Kew M, Van Damme P, Mphahlele MJ, Meheus A. Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications? Vaccine. 2001;19:3799–815. PMID: 11427251. doi:10.1016/S0264-410X(01)00108-6.
   PubMed Web of Science ®Google Scholar
• Seddigh-Tonekaboni S, Lim WL, Young B, Hou JL, Waters J, Luo KX, Thomas HC, Karayiannis P. Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patient. J Viral Hepat. 2001;8:154–58. PMID: 11264736. doi:10.1046/j.1365-2893.2001.00275.x.
   PubMed Web of Science ®Google Scholar